Successful treatment with rituximab for angioimmunoblastic T-cell lymphoma

Abstract We experienced a patient with angioimmunoblastic T-cell lymphoma (AITL) without Epstein–Barr virus-positive B (EBV-B) cells at initial presentation who progressed to AITL with expansion of EBV-B cells at relapse. Based on the results of repeated biopsy, the patient was successfully treated...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Leukemia research reports 2013, Vol.2 (1), p.36-38
Hauptverfasser:	Kasahara, Hidenori, Kakimoto, Tsunayuki, Saito, Hideaki, Akuta, Keigo, Yamamoto, Kazutaka, Ujiie, Hidetoshi, Sugahara, Hiroyuki, Hoshida, Yoshihiko, Sakoda, Hiroto
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioimmunoblastic T-cell lymphoma (AITL) Case Report EBV-DNA Epstein–Barr virus Hematology, Oncology and Palliative Medicine Pathology R-CHOP Rituximab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!